ROCKWELL MEDICAL, INC. Revenue from Contract with Customer, Including Assessed Tax
ROCKWELL MEDICAL, INC. (RMTI) reported Revenue from Contract with Customer, Including Assessed Tax of $17.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $17.78M, a 10.63% increase year-over-year.
- ROCKWELL MEDICAL, INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $17.34M, a 8.34% decline year-over-year.
- ROCKWELL MEDICAL, INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $18.35M, a 25.62% decline year-over-year.
- ROCKWELL MEDICAL, INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $15.93M, a 43.75% decline year-over-year.
- ROCKWELL MEDICAL, INC. revenue from contract with customer, including assessed tax for fiscal 2025 was $69.26M, a 31.76% decline from fiscal 2024.
- ROCKWELL MEDICAL, INC. revenue from contract with customer, including assessed tax for fiscal 2024 was $101.49M, a 21.38% increase from fiscal 2023.
- ROCKWELL MEDICAL, INC. revenue from contract with customer, including assessed tax for fiscal 2023 was $83.61M, a 14.84% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. revenue from contract with customer, including assessed tax for fiscal 2022 was $72.81M, a 17.57% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 12 month | Revenue from Contract with Customer, Including Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.78M 10-Q · filed 2026-08-13 | $35.12M 10-Q · filed 2026-08-13 | $53.46M derived: sum of 3 quarters · filed 2026-08-13 | $69.39M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $17.34M 10-Q · filed 2026-05-07 | $35.68M derived: sum of 2 quarters · filed 2026-05-07 | $51.61M derived: sum of 3 quarters · filed 2026-05-07 | $67.68M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $18.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $34.27M derived: sum of 2 quarters · filed 2026-03-26 | $50.34M derived: sum of 3 quarters · filed 2026-08-13 | $69.26M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $15.93M 10-Q · filed 2025-11-12 | $32.00M derived: sum of 2 quarters · filed 2026-08-13 | $50.91M 10-Q · filed 2025-11-12 | $75.58M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $16.07M 10-Q · filed 2026-08-13 | $34.98M 10-Q · filed 2026-08-13 | $59.65M derived: sum of 3 quarters · filed 2026-08-13 | $87.97M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $18.91M 10-Q · filed 2026-05-07 | $43.58M derived: sum of 2 quarters · filed 2026-05-07 | $71.89M derived: sum of 3 quarters · filed 2026-05-07 | $97.73M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $24.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $52.98M derived: sum of 2 quarters · filed 2026-03-26 | $78.81M derived: sum of 3 quarters · filed 2026-03-26 | $101.49M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $28.32M 10-Q · filed 2025-11-12 | $54.15M derived: sum of 2 quarters · filed 2025-11-12 | $76.82M 10-Q · filed 2025-11-12 | $98.92M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $25.83M 10-Q · filed 2025-08-14 | $48.51M 10-Q · filed 2025-08-14 | $70.60M derived: sum of 3 quarters · filed 2025-08-14 | $94.37M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $22.68M 10-Q · filed 2025-05-12 | $44.77M derived: sum of 2 quarters · filed 2025-05-12 | $68.54M derived: sum of 3 quarters · filed 2025-05-12 | $86.62M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $22.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $45.86M derived: sum of 2 quarters · filed 2025-03-20 | $63.94M derived: sum of 3 quarters · filed 2025-03-20 | $83.61M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $23.77M 10-Q · filed 2024-11-12 | $41.85M derived: sum of 2 quarters · filed 2024-11-12 | $61.52M 10-Q · filed 2024-11-12 | $80.83M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $18.08M 10-Q · filed 2024-08-08 | $37.75M 10-Q · filed 2024-08-08 | $57.06M derived: sum of 3 quarters · filed 2024-08-08 | $75.75M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $19.67M 10-Q · filed 2024-05-14 | $38.98M derived: sum of 2 quarters · filed 2024-05-14 | $57.67M derived: sum of 3 quarters · filed 2024-05-14 | $76.35M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $19.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $38.00M derived: sum of 2 quarters · filed 2024-03-21 | $56.69M derived: sum of 3 quarters · filed 2024-03-21 | $72.81M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $18.69M 10-Q · filed 2023-11-14 | $37.37M derived: sum of 2 quarters · filed 2023-11-14 | $53.50M 10-Q · filed 2023-11-14 | $68.83M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $18.68M 10-Q · filed 2023-08-14 | $34.81M 10-Q · filed 2023-08-14 | $50.14M derived: sum of 3 quarters · filed 2023-08-14 | $66.13M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $16.12M 10-Q · filed 2023-05-15 | $31.46M derived: sum of 2 quarters · filed 2023-05-15 | $47.44M derived: sum of 3 quarters · filed 2023-05-15 | $62.58M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $15.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $31.32M derived: sum of 2 quarters · filed 2023-03-30 | $46.46M derived: sum of 3 quarters · filed 2023-03-30 | $61.93M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $15.99M 10-Q · filed 2022-11-14 | $31.13M derived: sum of 2 quarters · filed 2022-11-14 | $46.60M 10-Q · filed 2022-11-14 | $61.76M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $15.14M 10-Q · filed 2022-08-15 | $30.61M 10-Q · filed 2022-08-15 | $45.77M derived: sum of 3 quarters · filed 2022-08-15 | $61.05M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $15.47M 10-Q · filed 2022-05-16 | $30.64M derived: sum of 2 quarters · filed 2022-05-16 | $45.92M derived: sum of 3 quarters · filed 2022-05-16 | $61.81M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $15.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $30.44M derived: sum of 2 quarters · filed 2022-04-08 | $46.34M derived: sum of 3 quarters · filed 2022-04-08 | $62.20M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $15.28M 10-Q · filed 2021-11-15 | $31.18M derived: sum of 2 quarters · filed 2021-11-15 | $47.03M 10-Q · filed 2021-11-15 | $62.52M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $15.90M 10-Q · filed 2021-08-16 | $15.90M 10-Q · filed 2020-08-10 | $31.75M 10-Q · filed 2021-08-16 | $31.75M 10-Q · filed 2020-08-10 | $47.24M derived: sum of 3 quarters · filed 2021-08-16 | $62.65M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $15.86M 10-Q · filed 2021-05-17 | $15.86M 10-Q · filed 2020-05-11 | $31.35M derived: sum of 2 quarters · filed 2021-05-17 | $46.76M derived: sum of 3 quarters · filed 2021-05-17 | $61.60M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $15.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $30.90M derived: sum of 2 quarters · filed 2021-03-31 | $45.74M derived: sum of 3 quarters · filed 2021-03-31 | $61.30M 10-K · filed 2021-03-31 | $61.30M 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $15.41M 10-Q · filed 2020-11-09 | $15.41M 10-Q · filed 2019-11-12 | $30.25M derived: sum of 2 quarters · filed 2020-11-09 | $45.81M 10-Q · filed 2020-11-09 | $45.81M 10-Q · filed 2019-11-12 | $62.67M derived: sum of 4 quarters · filed 2020-11-09 | ||
| 2019-06-30 | $14.85M 10-Q · filed 2020-08-10 | $30.41M 10-Q · filed 2020-08-10 | $47.26M derived: sum of 3 quarters · filed 2020-08-10 | $63.93M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $15.56M 10-Q · filed 2020-05-11 | $32.41M derived: sum of 2 quarters · filed 2020-05-11 | $49.09M derived: sum of 3 quarters · filed 2020-05-11 | $64.00M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $16.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $33.53M derived: sum of 2 quarters · filed 2020-03-17 | $48.44M derived: sum of 3 quarters · filed 2020-03-17 | $63.39M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | $16.67M 10-Q · filed 2019-11-12 | $31.59M derived: sum of 2 quarters · filed 2019-11-12 | $46.53M 10-Q · filed 2019-11-12 | $61.37M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $14.91M 10-Q · filed 2019-08-09 | $29.86M 10-Q · filed 2019-08-09 | $44.70M derived: sum of 3 quarters · filed 2019-08-09 | $59.33M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $14.95M 10-Q · filed 2019-05-10 | $29.79M derived: sum of 2 quarters · filed 2019-05-10 | $44.41M derived: sum of 3 quarters · filed 2019-05-10 | $57.66M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $14.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $29.46M derived: sum of 2 quarters · filed 2019-03-18 | $42.71M derived: sum of 3 quarters · filed 2019-03-18 | $57.30M 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | $14.63M 10-Q · filed 2018-11-09 | $27.87M derived: sum of 2 quarters · filed 2018-11-09 | $42.46M 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | $13.24M 10-Q · filed 2018-08-14 | $27.84M 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | $14.59M 10-Q/A · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |